Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
Primary level not completed |
Primary level of education |
Secondary level of education |
Higher level of education |
Base (known education level) |
Education level unknown |
|---|---|---|---|---|---|---|
Czech Republic |
12.6 |
56.2 |
30.3 |
1.0 |
938 |
34 |
Denmark |
15.6 |
50.8 |
30.3 |
3.3 |
1298 |
131 |
Germany |
25.3 |
46.4 |
27.1 |
1.2 |
8761 |
2140 |
Greece |
2.4 |
25.8 |
66.9 |
5.0 |
761 |
107 |
Cyprus |
1.8 |
52.7 |
37.3 |
8.2 |
110 |
5 |
Latvia |
14.0 |
46.9 |
37.8 |
1.4 |
143 |
0 |
Malta |
0.0 |
29.4 |
58.8 |
11.8 |
68 |
178 |
Netherlands |
14.3 |
42.1 |
37.3 |
6.2 |
3814 |
1290 |
Slovenia |
6.7 |
44.8 |
45.7 |
2.9 |
315 |
189 |
Slovakia |
7.1 |
46.6 |
45.8 |
0.5 |
365 |
38 |
Finland |
7.7 |
64.3 |
24.8 |
3.3 |
521 |
34 |
Sweden |
9.9 |
46.8 |
34.2 |
9.1 |
547 |
63 |
Bulgaria |
10.0 |
20.9 |
64.3 |
4.8 |
230 |
1 |
Total |
18.4 |
45.6 |
33.0 |
3.0 |
17871 |
4210 |
Notes: Only countries providing data are reported. Source: 2004 Reitox national reports - TDI - outpatient treatment centres – see [Table TDI-13] | ||||||